
Patrick T. Lewis
Examiner (ID: 16456, Phone: (571)272-0655 , Office: P/1672 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1623, 1621, 1693, 1691, 1672, 1673 |
| Total Applications | 1936 |
| Issued Applications | 1309 |
| Pending Applications | 238 |
| Abandoned Applications | 439 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18871146
[patent_doc_number] => 11858931
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-02
[patent_title] => Amino acid compounds with unbranched linkers and methods of use
[patent_app_type] => utility
[patent_app_number] => 17/679002
[patent_app_country] => US
[patent_app_date] => 2022-02-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 2
[patent_no_of_words] => 32445
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17679002
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/679002 | Amino acid compounds with unbranched linkers and methods of use | Feb 22, 2022 | Issued |
Array
(
[id] => 20343127
[patent_doc_number] => 12466849
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-11
[patent_title] => Anti-viral and anti-tumoral compounds
[patent_app_type] => utility
[patent_app_number] => 17/583378
[patent_app_country] => US
[patent_app_date] => 2022-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 76
[patent_figures_cnt] => 105
[patent_no_of_words] => 65301
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17583378
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/583378 | Anti-viral and anti-tumoral compounds | Jan 24, 2022 | Issued |
Array
(
[id] => 17790441
[patent_doc_number] => 20220249532
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-11
[patent_title] => COMBINATION THERAPY FOR HIV WITH ADENOSINE DERIVATIVE AND CAPSID INHIBITORS
[patent_app_type] => utility
[patent_app_number] => 17/583815
[patent_app_country] => US
[patent_app_date] => 2022-01-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27004
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -77
[patent_words_short_claim] => 202
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17583815
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/583815 | Combination therapy for HIV with adenosine derivative and capsid inhibitors | Jan 24, 2022 | Issued |
Array
(
[id] => 19316882
[patent_doc_number] => 20240238422
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-07-18
[patent_title] => Hypoimmunogenic Biotherapeutics
[patent_app_type] => utility
[patent_app_number] => 18/036844
[patent_app_country] => US
[patent_app_date] => 2022-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 59567
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18036844
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/036844 | Hypoimmunogenic Biotherapeutics | Jan 9, 2022 | Pending |
Array
(
[id] => 17546643
[patent_doc_number] => 20220117984
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-21
[patent_title] => METHODS OF USING HUMAN MILK OLIGOSACCHARIDES FOR IMPROVING AIRWAY RESPIRATORY HEALTH
[patent_app_type] => utility
[patent_app_number] => 17/562327
[patent_app_country] => US
[patent_app_date] => 2021-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19049
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17562327
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/562327 | Methods of using human milk oligosaccharides for improving airway respiratory health | Dec 26, 2021 | Issued |
Array
(
[id] => 17546643
[patent_doc_number] => 20220117984
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-21
[patent_title] => METHODS OF USING HUMAN MILK OLIGOSACCHARIDES FOR IMPROVING AIRWAY RESPIRATORY HEALTH
[patent_app_type] => utility
[patent_app_number] => 17/562327
[patent_app_country] => US
[patent_app_date] => 2021-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19049
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17562327
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/562327 | Methods of using human milk oligosaccharides for improving airway respiratory health | Dec 26, 2021 | Issued |
Array
(
[id] => 19096365
[patent_doc_number] => 20240115592
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-04-11
[patent_title] => PGC-1alpha EXPRESSION PROMOTING AGENT, MUSCLE-BUILDING AGENT AND MITOCHONDRIA ACTIVATING AGENT
[patent_app_type] => utility
[patent_app_number] => 18/257724
[patent_app_country] => US
[patent_app_date] => 2021-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5761
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18257724
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/257724 | PGC-1alpha EXPRESSION PROMOTING AGENT, MUSCLE-BUILDING AGENT AND MITOCHONDRIA ACTIVATING AGENT | Dec 26, 2021 | Pending |
Array
(
[id] => 18953583
[patent_doc_number] => 20240041910
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-02-08
[patent_title] => MUSCULAR ATROPHY INHIBITOR AND METHOD FOR INHIBITING MUSCULAR ATROPHY
[patent_app_type] => utility
[patent_app_number] => 18/258977
[patent_app_country] => US
[patent_app_date] => 2021-12-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5451
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18258977
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/258977 | MUSCULAR ATROPHY INHIBITOR AND METHOD FOR INHIBITING MUSCULAR ATROPHY | Dec 26, 2021 | Pending |
Array
(
[id] => 19403611
[patent_doc_number] => 20240287122
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-29
[patent_title] => NOVEL GALACTOSIDE INHIBITOR OF GALECTINS
[patent_app_type] => utility
[patent_app_number] => 18/258656
[patent_app_country] => US
[patent_app_date] => 2021-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27243
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18258656
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/258656 | NOVEL GALACTOSIDE INHIBITOR OF GALECTINS | Dec 19, 2021 | Pending |
Array
(
[id] => 19403611
[patent_doc_number] => 20240287122
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-29
[patent_title] => NOVEL GALACTOSIDE INHIBITOR OF GALECTINS
[patent_app_type] => utility
[patent_app_number] => 18/258656
[patent_app_country] => US
[patent_app_date] => 2021-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 27243
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18258656
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/258656 | NOVEL GALACTOSIDE INHIBITOR OF GALECTINS | Dec 19, 2021 | Pending |
Array
(
[id] => 19067161
[patent_doc_number] => 20240101587
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-28
[patent_title] => BIOMASS REMOVAL BY CENTRIFUGATION
[patent_app_type] => utility
[patent_app_number] => 18/257986
[patent_app_country] => US
[patent_app_date] => 2021-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20794
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18257986
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/257986 | BIOMASS REMOVAL BY CENTRIFUGATION | Dec 16, 2021 | Pending |
Array
(
[id] => 18707548
[patent_doc_number] => 20230330124
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-10-19
[patent_title] => NICOTINAMIDE MONONUCLEOTIDE DERIVATIVES AND USE THEREOF IN THE TREATMENT AND PREVENTION OF A RED BLOOD CELL DISORDER
[patent_app_type] => utility
[patent_app_number] => 18/028080
[patent_app_country] => US
[patent_app_date] => 2021-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16502
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 625
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18028080
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/028080 | Nicotinamide mononucleotide derivatives and use thereof in the treatment and prevention of a red blood cell disorder | Dec 16, 2021 | Issued |
Array
(
[id] => 19067161
[patent_doc_number] => 20240101587
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-03-28
[patent_title] => BIOMASS REMOVAL BY CENTRIFUGATION
[patent_app_type] => utility
[patent_app_number] => 18/257986
[patent_app_country] => US
[patent_app_date] => 2021-12-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20794
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18257986
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/257986 | BIOMASS REMOVAL BY CENTRIFUGATION | Dec 16, 2021 | Pending |
Array
(
[id] => 20371267
[patent_doc_number] => 12478682
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-25
[patent_title] => Nucleic acid conjugates and uses thereof
[patent_app_type] => utility
[patent_app_number] => 17/552750
[patent_app_country] => US
[patent_app_date] => 2021-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 36041
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17552750
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/552750 | Nucleic acid conjugates and uses thereof | Dec 15, 2021 | Issued |
Array
(
[id] => 17635007
[patent_doc_number] => 11345720
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-05-31
[patent_title] => Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereof
[patent_app_type] => utility
[patent_app_number] => 17/551592
[patent_app_country] => US
[patent_app_date] => 2021-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 47
[patent_figures_cnt] => 47
[patent_no_of_words] => 144078
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17551592
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/551592 | Efficient and scalable syntheses of nicotinoyl ribosides and reduced nicotinoyl ribosides, modified derivatives thereof, phosphorylated analogs thereof, adenylyl dinucleotide conjugates thereof, and novel crystalline forms thereof | Dec 14, 2021 | Issued |
Array
(
[id] => 17460285
[patent_doc_number] => 20220073590
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-10
[patent_title] => Fusion Albumin Nanoparticle and Application Thereof
[patent_app_type] => utility
[patent_app_number] => 17/532182
[patent_app_country] => US
[patent_app_date] => 2021-11-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4549
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17532182
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/532182 | Fusion albumin nanoparticle and application thereof | Nov 21, 2021 | Issued |
Array
(
[id] => 17627408
[patent_doc_number] => 20220162423
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-26
[patent_title] => Cellulose Ester Composition and Articles Made Therefrom
[patent_app_type] => utility
[patent_app_number] => 17/531336
[patent_app_country] => US
[patent_app_date] => 2021-11-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6538
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17531336
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/531336 | Cellulose ester composition and articles made therefrom | Nov 18, 2021 | Issued |
Array
(
[id] => 17546653
[patent_doc_number] => 20220117994
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-21
[patent_title] => METHOD OF PREVENTING OF SYSTEMIC-TO-PULMONARY-ARTERY SHUNT THROMBOSIS
[patent_app_type] => utility
[patent_app_number] => 17/513079
[patent_app_country] => US
[patent_app_date] => 2021-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9763
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17513079
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/513079 | METHOD OF PREVENTING OF SYSTEMIC-TO-PULMONARY-ARTERY SHUNT THROMBOSIS | Oct 27, 2021 | Abandoned |
Array
(
[id] => 18842633
[patent_doc_number] => 20230405037
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-12-21
[patent_title] => PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING THE SAME FOR TREATING CANCER
[patent_app_type] => utility
[patent_app_number] => 18/250674
[patent_app_country] => US
[patent_app_date] => 2021-10-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9228
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18250674
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/250674 | PHARMACEUTICAL COMPOSITIONS AND METHODS OF USING THE SAME FOR TREATING CANCER | Oct 26, 2021 | Pending |
Array
(
[id] => 19464085
[patent_doc_number] => 20240317754
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-26
[patent_title] => METHODS AND MODIFIED NUCLEOSIDES FOR TREATING CORONAVIRUS INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 18/270009
[patent_app_country] => US
[patent_app_date] => 2021-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17901
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18270009
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/270009 | METHODS AND MODIFIED NUCLEOSIDES FOR TREATING CORONAVIRUS INFECTIONS | Sep 14, 2021 | Pending |